ICU-acquired weakness is the most common neuromuscular injury in critically ill patients and an important issue that affects their long-term quality of life. Although ICU-acquired weakness has received increasing attention in recent years, there is still no consensus on its pathophysiological mechanisms, and there are knowledge gaps in identifying high-risk patients and subsequent treatment. This article summarizes the research on ICU-acquired weakness in terms of pathophysiological mechanisms, diagnostic methods, and treatment through a literature review.
No takes yet. Share an insight, caveat, or question.
Xue et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: